Author

A. Ohradanova-Repic

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 1

Frequent Co-Authors

H. Stockinger· 2 shared A. Bergthaler· 1 shared A. Hagelkruys· 1 shared A. Hladik· 1 shared A. Mirazimi· 1 shared B. Agerer· 1 shared C. Oostenbrink· 1 shared F. Oberndorfer· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

H. Stockinger

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by the N-terminal peptide of lactoferrin

A. Ohradanova-Repic, L. Gebetsberger, G. Tajti, G. Ondrovicova, R. Prazenicova, R. Skrabana, P. Barath, H. Stockinger, V. Leksa

This study identifies a lactoferrin-derived peptide that inhibits TMPRSS2-mediated SARS-CoV-2 spike protein processing and viral infection.

bioRxiv · Dec 20, 2021Immunology

ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology

R. Gawish, P. Starkl, L. Pimenov, A. Hladik, K. Lakovits, F. Oberndorfer, S. J. F. Cronin, A. Ohradanova-Repic, G. Wirnsberger, B. Agerer, L. Endler, T. Capraz, J. W. Perthold, A. Hagelkruys, N. Montserrat, , S. Knapp

This paper develops a mouse-adapted SARS-CoV-2 strain, maVie16, to model COVID-19 in mice, showing that ACE2 is critical for disease and that blocking TNF/IFNγ reduces immunopathology.

bioRxiv · Aug 9, 2021Immunology